86 related articles for article (PubMed ID: 19674115)
1. Recurrent dysosmia induced by pyrazinamide.
El Aïdli S; Kastalli S; Zaïem A; Lakhoua G; Rejeibi I; Loueslati MH; Daghfous R; Belkahia C
Fundam Clin Pharmacol; 2009 Oct; 23(5):539-41. PubMed ID: 19674115
[TBL] [Abstract][Full Text] [Related]
2. Olfactory disturbance related to pyrazinamide.
Tsou CC; Chien JY
QJM; 2014 Mar; 107(3):217-8. PubMed ID: 24023071
[No Abstract] [Full Text] [Related]
3. Pyrazinamide induced hyperuricaemia presenting as severe bilateral leg cramps.
Gupta S; Gupta V; Kapoor B; Kapoor V
J Indian Med Assoc; 2007 Jun; 105(6):341-2. PubMed ID: 18232182
[TBL] [Abstract][Full Text] [Related]
4. Pyrazinamide induced hyperuricemia in patients taking anti-tuberculous therapy.
Solangi GA; Zuberi BF; Shaikh S; Shaikh WM
J Coll Physicians Surg Pak; 2004 Mar; 14(3):136-8. PubMed ID: 15228843
[TBL] [Abstract][Full Text] [Related]
5. Antituberculous therapy-induced toxicity.
Bharat A; Vedkumar M; Subhash HS; Abraham OC; Mathai D
J Assoc Physicians India; 2003 May; 51():522-4. PubMed ID: 12974441
[TBL] [Abstract][Full Text] [Related]
6. Pyrazinamide-induced anaphylaxis: diagnosed by skin test and successful desensitization.
Bavbek S; Yılmaz I; Aydın Ö; Ozdemir SK
Int Arch Allergy Immunol; 2012; 157(2):209-12. PubMed ID: 21986254
[TBL] [Abstract][Full Text] [Related]
7. Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy.
Fernández-Solà J; Campistol JM; Miró O; Garcés N; Soy D; Grau JM
Nephrol Dial Transplant; 1996 Sep; 11(9):1850-2. PubMed ID: 8918638
[No Abstract] [Full Text] [Related]
8. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
Garca-Doval I
J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
[No Abstract] [Full Text] [Related]
9. Adverse drug reactions observed during DOTS.
Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Teo SK
Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
[TBL] [Abstract][Full Text] [Related]
11. [Effects of pyrazinamide on the liver in patients with tuberculosis. An ultrastructural study].
Pilheu JA; de Salvo MC; Arias RF; Koch OR
Medicina (B Aires); 1985; 45(1):15-9. PubMed ID: 3880102
[No Abstract] [Full Text] [Related]
12. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
Wada M
Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
[TBL] [Abstract][Full Text] [Related]
13. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
14. Is Hyperuricemia Overlooked when Treating Pediatric Tuberculosis Patients with Pyrazinamide?
Şişmanlar T; Aslan AT; Budakoğlu I
J Trop Pediatr; 2015 Oct; 61(5):351-6. PubMed ID: 26136257
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with pyrazinamide given in increased doses twice a week in combination with other drugs].
Pregowski W; Stańczuk-Holub A
Gruzlica; 1973 Jul; 41(7):795-802. PubMed ID: 4730980
[No Abstract] [Full Text] [Related]
17. [Hyperuricemia and arthralgia during pyrazinamide treatment].
Inoue T; Ikeda N; Kurasawa T; Sato A; Nakatani K; Ikeda T; Yoshimatsu H
Nihon Kokyuki Gakkai Zasshi; 1999 Feb; 37(2):115-8. PubMed ID: 10214039
[TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide-induced lichenoid photodermatitis.
Choonhakarn C; Janma J
J Am Acad Dermatol; 1999 Apr; 40(4):645-6. PubMed ID: 10188694
[No Abstract] [Full Text] [Related]
19. Taste and smell disturbance with the alpha-adrenoceptor agonist midodrine.
Young TM; Mathias CJ
Ann Pharmacother; 2004 Nov; 38(11):1868-70. PubMed ID: 15466905
[TBL] [Abstract][Full Text] [Related]
20. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
Stout JE
Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
